Alteration of the influences of HLA classes I and II alleles on the perinatal hepatitis B virus infection after immunoprophylaxis in Korean children

Hepatology Research

Volumn 35, Issue 2, 2006, Pages 118-126

  Kim, Jong Hyun ^a   Pyo, Chul Woo ^b   Koh, Dae Kyun ^a   Hur, Jae Kyun ^a   Kang, Jin Han ^a   Kim, Tai Gyu ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Hepatitis B immunoglobulin; Hepatitis B vaccine; Prophylaxis failure; Vertical transmission

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B35 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; IMMUNOPROPHYLAXIS; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MOTHER; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 33646802324     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.03.004     Document Type: Article

References (44)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. McMahon B.J., Alward W.L., Hall D.B., et al. Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 (1985) 599-603
3. Beasley R.P., Hwang L.Y., Lin C.C., et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet ii (1981) 388-393
4. Ip H.M., Lelie P.N., Wong V.C., Kuhns M.C., and Reesink H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet i (1989) 406-410
5. Lee P.I., Lee C.Y., Huang L.M., and Chang M.H. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 126 (1995) 716-721
6. Kim J.H., Kang J.H., and Oh C.K. Immune responses and efficacy of hepatitis B vaccine in neonates born from hepatitis B carrier mothers: focus on HBV-DNA. Korean J. Pediatr. 41 (1998) 1498-1508
7. Burk R.D., Hwang L.Y., Ho G.Y., Shafritz D.A., and Beasley R.P. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 170 (1994) 1418-1423
8. del Canho R., Grosheide P.M., Mazel J.A., et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 15 (1997) 1624-1630
9. Carman W.F., Zanetti A.R., Karayiannis P., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 (1990) 325-329
10. Oon C.J., Lim G.K., Ye Z., et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13 (1995) 699-702
11. Lee P.I., Chang L.Y., Lee C.Y., Huang L.M., and Chang M.H. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176 (1997) 427-430
12. Lee K.M., Kim Y.S., Ko Y.Y., et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16 (2001) 359-362
13. Nainan O.V., Khristova M.L., Byun K., et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 68 (2002) 319-327
14. Purcell R.H. Hepatitis B virus mutants and efficacy of vaccination. Lancet 356 (2000) 769-770
15. Koziel M.J. Immunology of viral hepatitis. Am J Med 100 (1996) 98-109
16. van Hattum J., Schreuder G.M., and Schalm S.W. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 7 (1987) 11-14
17. Mota A.H., Fainboim H., Terg R., and Fainboim L. Association of chronic active hepatitis and HLA B35 in patients with hepatitis B virus. Tissue Antigens 30 (1987) 238-240
18. Hacibektasoglu A., Barut A., and Inal A. Relationship of histocompatibility groups to chronic HBV infections. Mikrobiyol Bul 27 (1993) 241-248
19. Zavaglia C., Bortolon C., Ferrioli G., et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 24 (1996) 658-665
20. Almarri A., and Batchelor J.R. HLA and hepatitis B infection. Lancet 344 (1994) 1194-1195
21. Thursz M.R., Kwiatkowski D., Allsopp C.E., Greenwood B.M., Thomas H.C., and Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332 (1995) 1065-1069
22. Chen D.F., Kliem V., Endres W., et al. Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease. Scand J Gastroenterol 31 (1996) 1211-1215
23. Hohler T., Gerken G., Notghi A., et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 26 (1997) 503-507
24. Thio C.L., Carrington M., Marti D., et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 179 (1999) 1004-1006
25. Ahn S.H., Han K.H., Park J.Y., et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 31 (2000) 1371-1373
26. Obami-Itou V., Barry M.F., Raphenon G., et al. Serological HLA class I alleles in Senegalese blood donors detected HBs Ag positive. Immunol Lett 74 (2000) 229-232
27. Akcam Z., Sunbul M., Durupinar B., Eroglu C., Esen S., and Leblebicioglu H. Tissue types as prognostic risk factor in hepatitis B virus infection. Indian J Gastroenterol 21 (2002) 139-141
28. del Canho R., Grosheide P.M., Schalm S.W., de Vries R.R., and Heijtink R.A. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 20 (1994) 483-486
29. Terasaki P.I., Mandell M., Vandewater J., and Edginton T.S. Human blood lymphocyte cytotoxicity reactions with allogenic antisera. Ann N Y Acad Sci 120 (1964) 322-334
30. Bunce M., and Welsh K.I. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 43 (1994) 7-17
31. Jordan F., McWhinnie A.J., Turner S., et al. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 45 (1995) 103-110
32. Haldane J.B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20 (1956) 309-311
33. Kane M. Global programme for control of hepatitis B infection. Vaccine 13 Suppl 1 (1995) S47-S49
34. Craven D.E., Awdeh Z.L., Kunches L.M., et al. Nonresponsiveness to hepatitis B vaccine in health care workers, Results of revaccination and genetic typings. Ann Intern Med 105 (1986) 356-360
35. Peces R., de la Torre M., Alcazar R., and Urra J.M. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 29 (1997) 239-245
36. Hohler T., Meyer C.U., Notghi A., et al. The influence of major histocompatibility complex class II genes and T-cell Vβ repertoire on response to immunization with HBsAg. Hum Immunol 59 (1998) 212-218
37. Martinetti M., de Silvestri A., Belloni C., et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 97 (2000) 234-240
38. Martinetti M., Cuccia M., Daielli C., et al. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine 13 (1995) 555-560
39. Mineta M., Tanimura M., Tana T., Yssel H., Kashiwagi S., and Sasazuki T. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 8 (1996) 525-531
40. Thio C.L., Thomas D.L., and Carrington M. Chronic viral hepatitis and the human genome. Hepatology 31 (2000) 819-827
41. Bosi I., Ancora G., Mantovani W., et al. HLA DR13 and HCV vertical infection. Pediatr Res 51 (2002) 746-749
42. Winchester R., Chen Y., Rose S., Selby J., and Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A 92 (1995) 12374-12378
43. Hill A.V., Allsopp C.E., Kwiatkowski D., et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 352 (1991) 595-600
44. Song E.Y., Park M.H., Kang S.J., et al. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 59 (2002) 475-486